Allergy studies
Welcome to the NACE Allergy Studies Directory. Here you will find a list of the drug, food, insect and respiratory allergy research underway across Australia.
People living with allergic disease and members of the wider community can see which studies are currently accepting participants, while researchers can list new studies and gain an overview of the research happening in their field. The studies listed include: prevention, treatment and observational research.
The national Allergy Studies Directory currently includes food allergy studies accepting participants. We will include drug, insect and respiratory studies in the coming weeks. Stay tuned!
| Study name | Study focus | Study aim | Recruiting in | Who can participate? | Participant allergy status |
|---|---|---|---|---|---|
| PrEggNut | Prevention | To test whether the amount of eggs and peanuts a mother eats during pregnancy and breastfeeding has an influence on her baby’s food allergy development |
WA, SA, VIC, NSW
|
Pregnant women, less than 23 weeks gestation |
Baby to have family history of allergy |
| OPTIMUM | Prevention | To investigate if giving a dose of 'whole-cell' whooping cough vaccine between 6 and 12 weeks of age, instead of the 'acellular' whooping cough vaccine can help protect against allergy |
Infants, aged 6-12 weeks |
All welcome |
|
| LMNOP Pilot Study | Treatment | To investigate whether low dose multi-nut oral immunotherapy using a personalised combination of two nut flours is effective, safe and tolerable in preschool children with multi-nut allergy |
VIC
|
Children, aged 18-36 months |
Food allergy to two of peanut, almond, cashew, hazelnut or walnut |
| ERNIE | Treatment | To investigate the safety and tolerability of pragmatic, food-based, low dose multi-nut (almond, cashew, hazelnut, peanut and walnut) oral immunotherapy |
WA
|
Children, aged 1-5 years (first visit before 6th birthday) |
Food allergy - one or more nut allergies (almond, cashew, hazelnut, peanut, walnut) |
| Novartis CQGE031 Study | Treatment | To determine whether the medication Ligelizumab can decrease sensitivity to peanuts in children/adolescents with severe peanut allergy when given monthly by injection for 1 year |
VIC, QLD, WA, SA
|
Adolescents aged 12-17 years from early 2022, and children aged 6-11 years from late 2022 |
Food allergy - peanut |
Remember, the NACE is unable to directly administer any of the studies listed on our website. For enquiries about specific research, please contact the study directly.
Individuals and families
Want to take part in allergy research?
The NACE lists food, drug, insect and respiratory allergy prevention and treatment studies currently accepting participants across Australia.
Sign up to receive an email alert each time a new study is listed.
Researchers
Recruiting for an allergy study?
The NACE Allery Studies Directory is an opportunity to promote your research during recruitment, it also provides an overview of what studies are already underway in your field. List your trial on the Directory.
Proudly in partnership with the National Allergy Council and allergy organisations
